Literature DB >> 2541742

Consequences of angiotensin-converting enzyme inhibitor overdose.

A Varughese1, A A Taylor, E B Nelson.   

Abstract

Overdose with angiotensin-converting enzyme (ACE) inhibitors is still a relatively underreported phenomenon. We report here a case of an unintentional overdose of enalapril (100 mg) together with other medications. The patient experienced no adverse consequences. Pharmacokinetic evaluation revealed a t 1/2 for enalaprilat (prodrug) of seven hours and for enalapril at 36 hours. Based on this case report as well as others, guidelines for assessment and treatment of these patients are proposed. Management of hypotension is the primary therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541742     DOI: 10.1093/ajh/2.5.355

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Profound prolonged hypotension following captopril overdose.

Authors:  C S Barr; R Payne; R W Newton
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System.

Authors:  A M Vilay; C S Wong; R M Schrader; R C Mercier; S A Seifert
Journal:  Clin Toxicol (Phila)       Date:  2013-01-19       Impact factor: 4.467

3.  Rapid onset of haemodynamic effects after angiotensin converting enzyme-inhibitor overdose: implications for initial patient triage.

Authors:  C Lucas; G A Christie; W S Waring
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

4.  Enalapril overdose and the corrective effect of intravenous angiotensin II.

Authors:  D E Newby; M R Lee; A J Gray; N A Boon
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

5.  Redefining the ACE-inhibitor dose-response relationship: substantial blood pressure lowering after massive doses.

Authors:  G A Christie; C Lucas; D N Bateman; W S Waring
Journal:  Eur J Clin Pharmacol       Date:  2006-11-07       Impact factor: 2.953

Review 6.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.